North America BRIC Diabetes Care Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America BRIC Diabetes Care Devices Market
Brand: Bussiness Insights

North America BRIC Diabetes Care Devices Market: by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices, Continuous Glucose Monitoring Devices, Smart Insulin Pens, Diabetes Management Apps, Others), Application (Self/Home Care, Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Academic & Research Institutions, Others), Distribution Channels (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Diabetes Clinics, Supermarkets/Hypermarkets, Others), Technology (Wearable Technology, Non-invasive Technology, Smartphone-connected Devices, Implantable Devices, Traditional Devices, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20340 | Author: Manisha C

RD TOC Segmentation Research Methodology Request For Free Sample

North America BRIC Diabetes Care Devices Market: 2025–2035 Outlook

The North America BRIC Diabetes Care Devices market encompasses a wide range of innovative solutions aimed at enhancing diabetes management and improving patient outcomes. This market includes blood glucose monitoring devices, insulin delivery systems, continuous glucose monitoring (CGM) tools, smart insulin pens, and advanced management apps. The rising prevalence of diabetes, increasing health awareness, and rapid technological advancements are key forces shaping this sector. As a result, healthcare providers and patients are turning increasingly to digital solutions and next-generation devices. The drive towards remote patient monitoring, the emergence of non-invasive technologies, and a focus on user-friendly, integrated devices further accelerate market growth.

Latest Market Dynamics

Key Drivers

Rapid adoption of continuous glucose monitoring (CGM) systems: In 2025, Dexcom’s latest G7 CGM launch supports the trend towards real-time data and improved glycemic control, leading to broader acceptance among healthcare professionals and patients.

Expansion of wearable technology in diabetes care: Medtronic’s MiniMed 780G system highlights the move toward closed-loop solutions for automated insulin delivery, as patients and providers demand integrated, low-effort management tools.
Rising integration of AI and big data analytics: Companies like Tandem Diabetes Care are embedding AI algorithms to optimize insulin dosing and predict glucose trends, driving the industry toward smarter, data-driven care models.

Non-invasive glucose monitoring advancements: Senseonics Holdings and others are investing in implantable and needle-free solutions, addressing user discomfort and boosting adoption for those reluctant to use traditional finger-prick devices.
Telehealth and remote diabetes management: Rising demand for remote patient monitoring, driven by cross-platform apps and CGM data integration (e.g., Insulet’s Omnipod 5), opens new growth avenues in care continuity and personalized treatment.

In 2025, continuous glucose monitoring devices are projected to command the largest market share in North America, reflecting an accelerating shift from traditional blood glucose meters towards real-time, data-driven management solutions. Blood glucose monitoring devices continue to be a core part of diabetes care, while the uptake of smart insulin pens and digital management apps is increasing due to patient demand for convenience and connectivity. Insulin delivery devices also maintain significant market presence as personalized dosing and advanced delivery systems become embedded into standard care routines.

Self and home care remain dominant in the diabetes device application segment in North America, capturing the largest share in 2025. The convenience of monitoring at home, coupled with rising adoption of digital self-management platforms, drives this preference. Hospitals and clinics follow, as advanced devices support complex patient needs in clinical settings. Diagnostic centers and ambulatory surgical centers make up a smaller percentage, while research and academic institutions are primarily focused on device trials, validation, and training.

The North America BRIC Diabetes Care Devices market has shown robust revenue growth, increasing steadily year-on-year from 2020 to 2035, driven by greater disease prevalence and technology adoption. In 2025, revenue is estimated at $3,800 million and is forecast to reach over $8,700 million by 2035. This growth reflects both increased device penetration in outpatient and home settings, and the rapid uptake of advanced monitoring and delivery systems. Market expansion is sustained by ongoing healthcare digitization and a strong shift towards personalized, real-time diabetes management.

Year-on-year growth for the North America BRIC Diabetes Care Devices market is projected to range between 7% and 11% from 2020 to 2030, with a slightly moderated pace as the market matures towards 2035. The highest growth is expected around 2025, coinciding with regulatory approvals of next-generation CGMs and smart delivery systems. The growth rate normalizes as device adoption becomes mainstream and market penetration increases across both clinical and home care applications.

Medtronic, Abbott Laboratories, and Dexcom jointly hold the largest portion of the North America BRIC Diabetes Care Devices market in 2025. Their dominance is driven by robust R&D pipelines, extensive product portfolios, and established distribution networks. Other leading participants, including Becton Dickinson, Johnson & Johnson, and Roche, also secure significant shares owing to continuous innovation and strategic partnerships. The market remains moderately fragmented beyond the top firms due to the entry of digital-native companies.

Individual consumers represent the largest share of device buyers in North America, propelled by the growth in at-home diabetes management and increased awareness. Hospitals and clinics also make up a substantial portion, purchasing advanced devices for inpatient and outpatient care. Other buyer groups, including pharmacies and research institutions, account for smaller but rising shares, driven by the expanding role of digital therapeutics and training programs.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	3800
Regions	US, Canada, Mexico
Segments	Blood Glucose Monitoring Devices, Insulin Delivery Devices, Continuous Glucose Monitoring Devices, Smart Insulin Pens, Diabetes Management Apps, Others; Self/Home Care, Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Academic & Research Institutions, Others
Players	Medtronic, Abbott Laboratories, F. Hoffmann-La Roche AG, Dexcom, Becton Dickinson, Johnson & Johnson, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, Senseonics Holdings, Ypsomed, Sanofi, Novo Nordisk, Eli Lilly and Company, Terumo Corporation

June 2024: Dexcom launches G7 CGM in North America, emphasizing expanded integration with major health apps.
July 2024: Abbott secures FDA approval for its first over-the-counter CGM sensor, broadening access for Type 2 diabetes patients.
August 2024: Medtronic announces a partnership with Apple to enable seamless data sharing from MiniMed pumps to iOS devices.
September 2024: Insulet unveils Omnipod 5 for pediatric populations in Canada, featuring advanced algorithm-based insulin delivery.
October 2024: Tandem Diabetes Care rolls out new t:slim X2 software with AI-based dosing for enhanced glycemic outcomes.

About the Author

Manisha C

Lead Industry Analyst

Manisha C is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Manisha C brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Manisha C has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America BRIC Diabetes Care Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America BRIC Diabetes Care Devices Market: 2025–2035 Outlook

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America BRIC Diabetes Care Devices Market Share by Type, 2025

North America BRIC Diabetes Care Devices Market Share by Application, 2025

North America BRIC Diabetes Care Devices Market Revenue, 2020–2035 (USD Million)

North America BRIC Diabetes Care Devices Market Year-over-Year Growth, 2020–2035 (%)

North America BRIC Diabetes Care Devices Market Share by Country, 2025

North America BRIC Diabetes Care Devices Market Share by Top Players, 2025

North America BRIC Diabetes Care Devices Market Share by Buyers, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports